期刊文献+

左乙拉西坦pH敏感鼻用凝胶在大鼠体内的药代动力学研究 被引量:2

Pharmacokinetics of levetiracetam pH sensitive nasal gel in rats
原文传递
导出
摘要 目的研究左乙拉西坦(LEV)p H敏感鼻用凝胶在大鼠体内的药代动力学。方法用高效液相色谱法测定大鼠血中LEV的浓度。色谱柱为Wondasil C_(18)柱(250.0 mm×4.6 mm,5.0μm),流动相为乙腈-水(11∶89),检测波长为205 nm,内标为甲硝唑。按照体质量将大鼠随机分为实验组和对照组,每组6只。对照组按10.0 mg·kg^(-1)的剂量灌胃给予0.1%LEV溶液;实验组按1.0 mg·kg^(-1)的剂量鼻腔给予LEV pH敏感鼻用凝胶。用3P97药代动力学软件计算主要药代动力学参数。结果实验组和对照组的主要药代动力学参数如下:t_(max)分别为(0.08±0.01)和(0.75±0.10)h,C_(max)分别为(5.22±0.91)和(10.79±2.62)μg·mL^(-1),AUC_(0-t)分别为(9.72±0.99)和(35.10±11.60)μg·mL^(-1)·h,AUC_(0-∞)分别为(10.43±1.37)和(39.54±13.24)μg·mL^(-1)·h。实验组的t_(max)明显小于对照组,差异有统计学意义(P<0.01)。LEV pH敏感鼻用凝胶的相对生物利用度为275.05%。结论LEV p H敏感鼻用凝胶在大鼠体内吸收快、生物利用度高。 Objective To study the pharmacokinetics of levetiracetam(LEV)pH-sensitive nasal gel in rats.Methods The concentrations of LEV in rat plasma were determined by high performance liquid chromatography.The chromatographic analysis was performed on a Wondasil C_(18) reversed phase column(250.0 mm×4.6 mm,5.0μm).The mobile phase consisted of acetonitrile and water(11∶89)and the detection wavelength was set at 205 nm.Metronidazole was used as internal standard.The rats were randomly divided into experimental group and control group with 6 rats in each group.LEV p H-sensitive nasal gel was nasally administered to the experimental group at a dose of 1.0 mg·kg^(-1) and 0.1%LEV solution was given intragastricaly to the control group at a dose of 10.0 mg·kg^(-1).The main pharmacokinetic parameters of LEV in two groups were calculated by 3P97 pharmacokinetic programe.Results The main pharmacokinetic parameters of LEV for the experimental group and control group were as follows:t_(max) were(0.08±0.01)and(0.75±0.10)h,C_(max) were(5.22±0.91)and(10.79±2.62)μg·mL^(-1),AUC_(0-t) were(9.72±0.99)and(35.10±11.60)μg·mL^(-1)·h,AUC_(0-∞) were(10.43±1.37)and(39.54±13.24)μg·mL^(-1)·h,respectively.t_(max) for the experimental group was obviously smaller than that of control group.There was significant difference in t_(max) between experimental and control groups(P<0.01).The relative bioavailability(F_(r))of the drug p H-sensitive nasal gel was found to be 275.05%.Conclusion LEV pH-sensitive nasal gel shows fast absorption and high bioavailability in vivo.
作者 李爽 黄晶 谷福根 LI Shuang;HUANG Jing;GU Fu-gen(School of Pharmacy,Inner Mongolia Medical University,Hohhot 010110,Inner Mongolia Autonomous Region,China;Department of Pharmacy,Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010050,Inner Mongolia Autonomous Region,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2022年第2期147-150,共4页 The Chinese Journal of Clinical Pharmacology
关键词 左乙拉西坦 pH敏感鼻用凝胶 高效液相色谱 药代动力学 levetiracetam pH-sensitive nasal gel high performance liquid chromatography pharmacokinetics
  • 相关文献

参考文献7

二级参考文献46

  • 1肖拥军,罗湘冀.高效液相色谱法测定左乙拉西坦片的含量[J].广东药学院学报,2005,21(6):687-688. 被引量:7
  • 2Blonk MI,van der Nagel BC,Smit LS,et al.Quantification of leve-tiracetam in plasma of neonates by ultra performance liquidchromatog-raphy-tandem mass spectrometry[J].J Chromatogr B Analyt Tech-nol Biomed Life Sci,2010;878:675-681.
  • 3Juenke JM,Brown PI,Johnson-Davis KL,et al.Simultaneousquantification of levetiracetam and gabapentin in plasma by ultra-pressure liquid chromatography coupled with tandem mass spectrome-try detection[J].Ther Drug Monit,2011;33:209-231.
  • 4Contin M,Mohamed S,Albani F,et al.Simple and validated HPLC-UV analysis of levetiracetam in deproteinized plasma of patientswith epilepsy[J].J Chromatogr B Analyt Technol Biomed Life Sci,2008;873:129-132.
  • 5NIESPODZIANY I, KLITGAARD H, MARGINEANU DG. Levetiracetam : modulation of high voltage activated Ca^2 + current in Cal pyramidal neurons of rat hippocampal slices [ J ]. Epilepsia, 2000,41 ( Suppl 7 ) :S37.
  • 6NIESPODZIANY I, KLITGAARD H, MARGINEANU DG. Levetiracetam inhibits the high-voltage-activated Ca^2 + current in pyramidal neurones of rat hippoeampal slices[ J]. Neurosci Lett, 2001 , 306 ( 1/2 ) :5 - 8.
  • 7LUKYANETZ EA, SHKRYL VM, KOSTYUK PG .Selective blockade of N-type calcium channels by levetiracetam [ J ]. Epilepsia, 2002,43( 1 ) :9 - 18.
  • 8SIRVEN Jl. Neurocysticercosis: nursing perspectives[ J]. J Neurosci Nurs, 2002,34( 5 ) :237 - 241.
  • 9GLAUSER TA, PELLOCK JM, BEBIN EM,et al. Efficacy and safety of levetiracetam in children with partial seizures: an openlabel trial [ J ]. Epilepsia, 2002,43 ( 5 ) :518 - 524.
  • 10GLAUSER TA,AYALA R,ELTERMAN RD,et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures [ J ]. Neurology,2006,66( 11 ) : 1654 - 1660.

共引文献59

同被引文献14

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部